Pancreatic cancer cells resistant to chemoradiotherapy rich in "stem-cell-like" tumor cells.
about
Molecular therapeutics in pancreas cancerBioengineering Models for Breast Cancer ResearchMolecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancersEstablishment and characterization of a highly tumourigenic and cancer stem cell enriched pancreatic cancer cell line as a well defined model systemThe Metastatic Potential and Chemoresistance of Human Pancreatic Cancer Stem CellsLarge-scale pharmacological profiling of 3D tumor models of cancer cells.Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer cells.Using SV119-gold nanocage conjugates to eradicate cancer stem cells through a combination of photothermal and chemo therapies.Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics.Gemcitabine-based chemoradiotherapy followed by surgery for borderline resectable and locally unresectable pancreatic ductal adenocarcinoma: significance of the CA19-9 reduction rate and intratumoral human equilibrative nucleoside transporter 1 exprIdentification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines.Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.Current immunotherapeutic approaches in pancreatic cancer.Epithelial-Mesenchymal Transition in tumor microenvironment.Targeting tumor-initiating cancer cells with dCD133KDEL shows impressive tumor reductions in a xenotransplant model of human head and neck cancerAntisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer.Long noncoding RNA MALAT-1 enhances stem cell-like phenotypes in pancreatic cancer cellsCancer vaccination drives Nanog-dependent evolution of tumor cells toward an immune-resistant and stem-like phenotype.Neoadjuvant chemotherapy with gemcitabine for pancreatic cancer increases in situ expression of the apoptosis marker M30 and stem cell marker CD44.The role of epithelial-mesenchymal transition in pancreatic cancerTelomeres and Telomerase in the Radiation Response: Implications for Instability, Reprograming, and Carcinogenesis.The Role of EMT in Pancreatic Cancer ProgressionThe emerging roles of Oct4 in tumor-initiating cells.Targeting stemness is an effective strategy to control EML4-ALK+ non-small cell lung cancer cells.Hedgehog Signaling Regulates Epithelial-Mesenchymal Transition in Pancreatic Cancer Stem-Like Cellsc-MET inhibition enhances the response of the colorectal cancer cells to irradiation in vitro and in vivoThe effects of wenxin keli on p-wave dispersion and maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation: a meta-analysis of randomized controlled trials.EZH2 is required for breast and pancreatic cancer stem cell maintenance and can be used as a functional cancer stem cell reporter.Vitamin D receptor signaling and pancreatic cancer cell EMT.CD44(+) gastric cancer cells with stemness properties are chemoradioresistant and highly invasive.The embryonic transcription factor Brachyury blocks cell cycle progression and mediates tumor resistance to conventional antitumor therapies.PSCA and Oct-4 expression in the benign and malignant lesions of gallbladder: implication for carcinogenesis, progression, and prognosis of gallbladder adenocarcinoma.Multifunctional roles of urokinase plasminogen activator (uPA) in cancer stemness and chemoresistance of pancreatic cancer.Radiation induces the generation of cancer stem cells: A novel mechanism for cancer radioresistanceAltered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.Induced cancer stem cells generated by radiochemotherapy and their therapeutic implications.CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges.MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells.Therapy-induced enrichment of putative lung cancer stem-like cells.Membrane drug transporters and chemoresistance in human pancreatic carcinoma.
P2860
Q26751709-2CC17CF9-838C-4024-BFAB-AE03A527C601Q26770495-5E59C20D-5880-4C09-90D7-4FFD18A4DFBCQ26822406-0AF29961-2FE0-470F-95E0-C81BBF6694A1Q28485145-32F21BB5-3FE5-4AD1-AAC2-21EC4766296CQ28550040-24EC110D-C608-4F30-B961-D65CC1F453D5Q30364972-993DDE86-442B-4D91-AAE1-EAD89CF6E92AQ33735050-9792C175-93DD-4E52-BD5A-672373A8AB6EQ34052669-B4C2D2A2-8EC0-414D-8FD1-743A2BB0CCC3Q34067873-4E4102F7-AFD9-431C-8251-DBBD0AC2BE64Q34408283-BE1D7AFD-03BA-4DAA-B18E-6DEB06D0BEB8Q34613006-F3F91EFF-D859-4EC5-BA0F-88156FC96520Q35156211-08F40A77-0D5D-4AAC-AF7F-6643551B7432Q35212837-47D5EA2E-F4BB-47E5-A767-C228B7BABF58Q35230386-C46DE222-E6DF-4B8C-811D-51D737AFDEA4Q35317540-19C2700A-4113-41B4-A7B7-FC9B851D8B0EQ35552798-29236273-3D62-4119-B23D-FD6B87AA2440Q35585395-40FA57C1-40EF-4058-B303-356B99CC4064Q35871717-F4070394-E29F-49A0-8082-EB5FE472B1AEQ36084344-A69D4A47-70B4-4053-9B5D-69E52C37FFF8Q36097197-1F74A569-2A78-4080-A702-A337323A514DQ36309657-B32FBEA5-8C9B-45C1-9A45-9DA00754599BQ36379750-441C6E4A-3C36-46F5-89BF-49003DF2F258Q36498067-09E48A65-1D9A-4FAD-BA8D-0493D9FD18FEQ36545592-6B0E6861-489D-49AB-8077-08BA812B5A87Q36567892-3DB3539B-82F2-4466-A18B-81FC50597789Q36741686-CA6FB811-25CE-456C-9D81-BB9F2CA16DC3Q36801789-3F1553B7-A936-4B5F-A000-C8924E8E348CQ36861707-F592312A-052C-4485-ABCB-2D7152474609Q36935182-2588D004-D1F2-4FD5-A94F-1B2B1102C475Q36981362-741A7164-0D64-43A4-88CD-B18C550CF44CQ36985133-826BE47F-1A97-46C4-8A36-6784489A6491Q37104978-05E29B1A-CFB8-43D5-AD61-B0E86A47D5EEQ37131462-7FEE5DC2-C71B-40A0-9C11-AC147AD989E7Q37406832-ADA48448-805A-45DB-8159-E1AAA5B9398BQ37610799-6DD291EB-0520-48A0-8622-04C8A8468DE7Q37725612-66CB1EEB-F884-42F9-8E54-B35F093C73E8Q38035206-A977768F-CCF8-49FC-9EB7-309A56D5BD09Q38086010-B1E30E8B-4562-4913-9F40-FBF9D030B157Q38150766-11B68F2B-C829-491E-984F-8449C912E222Q38161328-5BFB5900-8BB5-42C4-B737-003E01FFC811
P2860
Pancreatic cancer cells resistant to chemoradiotherapy rich in "stem-cell-like" tumor cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pancreatic cancer cells resist ...... "stem-cell-like" tumor cells.
@ast
Pancreatic cancer cells resist ...... "stem-cell-like" tumor cells.
@en
type
label
Pancreatic cancer cells resist ...... "stem-cell-like" tumor cells.
@ast
Pancreatic cancer cells resist ...... "stem-cell-like" tumor cells.
@en
prefLabel
Pancreatic cancer cells resist ...... "stem-cell-like" tumor cells.
@ast
Pancreatic cancer cells resist ...... "stem-cell-like" tumor cells.
@en
P2093
P2860
P1476
Pancreatic cancer cells resist ...... "stem-cell-like" tumor cells.
@en
P2093
Chenghong Peng
Chengjian Shi
Cuifeng Wei
Zhiyong Du
P2860
P2888
P304
P356
10.1007/S10620-010-1340-0
P577
2010-08-04T00:00:00Z
P6179
1040806607